Novel combination with efti has met the trial’s primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are ...

Eventually, though, Hetlage’s primary doctor ordered a scan of her calf that showed a tumor, and a biopsy led to the ...

CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across ...

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April. The post Up 34% since April, ASX 300 ...

A runner, Judith Hetlage repeatedly felt pain in her left lower leg while on her daily path around Davie, Florida.

Teens are normally worried about school, friends, and what their weekend plans consist of, but for 14-year-old Bo Opperman, he has heavier concerns weighing on his mind.

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

Chemotherapy-free approach shows promising tumour response ahead of surgery Immutep Limited (ASX:IMM; NASDAQ:IMMP) has ...